The foundation of a hydrated,* healthy-looking skin.1
SKINVIVE™ by JUVÉDERM® is the hyaluronic acid injectable filler that delivers up to 9 months of deep† hydration,‡ with just one treatment.#,3-5
Developed with global skin health experts from the world’s #1 brand of hyaluronic acid injectable facial fillers.**,6
Suitable for treatment on the face, neck, decolletage, and hands.3,7,8
* Data from online interviews conducted with 12,360 “aesthetically aware” adults, both women and men aged 25-64 years, across 15 countries. 2
† Skin hydration was measured using the MoistureMeterD instrument with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively). 4
‡ Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1, 4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) and top-up treatment administered at Day 30 (n=31). 4
# Based on a search of published clinical studies of injectable Hyaluronic Acid treatments. A duration of 9 months was established with SKINVIVE™.5
** Based on HCP tracking market research involving over 1,700 HCPs from 16 international markets.6
1. Allergan Aesthetics. Data on file ALL-AGNA-220122. The Future of Aesthetics Global Trends Report. July 2022.
2. Allergan Aesthetics. Data on file Consumer Beauty Insights Survey 2021. August 2021.
3. SKINVIVE™ by JUVÉDERM® IFU. 20089473. Revision 2024-11-25.
4. Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791-798.
5. Allergan Aesthetics. Unpublished data. SKINVIVE™ by JUVÉDERM® –9-month duration of skin hydration in clinical trials. March 2023.
6. Allergan Aesthetics. Unpublished data. JUVÉDERM®, the world’s leading brand of hyaluronic acid facial fillers.REF-108642. March 2023.
7. Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):1065-1070.
8. Ogilvie P et al. Clin Cosmet Investig Dermatol 2020;13:267-74.
Hyaluronic acid gel (12mg/mL) with 0,3% lidocaine hydrocloride - 2 syringes Χ 1mL
Adverse Events must be reported to AbbVie (tel: 2144165555, email: greekpv@abbvie.com) and
For events from the use of a medical device, for Greece: tel. 2132040528/542 or visit the website: https://www.eof.gr/ web/ guest/ whitegeneral or via email at: vigilancematerial@eof.gr, and for Cyprus: tel. 22 605785/735/572 or via email at: cymda@mphs.moh.gov.cy.
